Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats - PubMed (original) (raw)
Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats
T M Mason et al. Diabetes. 1999 Mar.
Abstract
Prolonged exposure of pancreatic islets to free fatty acids (FFAs) inhibits glucose-stimulated insulin secretion (GSIS) in vitro. However, FFA inhibition of GSIS has not been clearly demonstrated in vivo. We examined the in vivo effect of prolonged elevation of plasma FFAs on GSIS using a two-step hyperglycemic clamp in rats treated with a 48-h intravenous infusion of either 20% Intralipid plus heparin (INT) (5 microl/min plus heparin, 0.1 U/min; n = 8), oleate (OLE) (1.3 microEq/min; n = 6), saline (SAL) (n = 6), or bovine serum albumin (BSA) (vehicle for OLE; n = 5). Because there was no difference in any of the parameters between BSA and SAL rats, these groups were combined as control rats (CONT) (n = 11). At the end of the 48-h OLE/INT/CONT infusions, after an overnight fast, plasma glucose was clamped for 2 h at 13 mmol/l and for another 2 h at 22 mmol/l. Preclamp plasma FFAs were elevated twofold (P < 0.01) versus CONT with both INT and OLE (NS, INT vs. OLE). Preclamp glucose, insulin, and C-peptide levels were higher in INT than in CONT rats (P < 0.05), suggesting insulin resistance, but they were not different in OLE and CONT rats. The insulin and C-peptide responses to the rise in plasma glucose from basal to 13 mmol/l were lower in OLE (336 +/- 72 pmol/l and 1.2 +/- 0.1 nmol/l, P < 0.01 and P < 0.05, respectively) than in CONT (552 +/- 54 and 1.9 +/- 0.1) rats, but they were not different between CONT and INT rats (648 +/- 150 and 2.0 +/- 0.4). The insulin and C-peptide responses to the rise in plasma glucose from 13 to 22 mmol/l were lower in both INT (1,188 +/- 204 pmol/l and 3.0 +/- 0.3 nmol/l, P < 0.01 and P < 0.001) and OLE (432 +/- 60 and 1.7 +/- 0.2, P < 0.001 vs. CONT or INT) rats than in CONT rats (1,662 +/- 174 and 5.0 +/- 0.6). In summary, 1) both INT and OLE decreased GSIS in vivo in rats, and 2) the impairing effect of INT on GSIS was less than that of OLE, which might be due to the different type of fatty acid (mostly polyunsaturated in INT versus monounsaturated as OLE) and/or to differential effects of INT and OLE on insulin sensitivity. In conclusion, prolonged elevation of plasma FFAs can desensitize the insulin secretory response to glucose in vivo, thus inducing a beta-cell defect that is similar to that found in type 2 diabetes.
Similar articles
- Effects of different free fatty acids on insulin resistance in rats.
Han P, Zhang YY, Lu Y, He B, Zhang W, Xia F. Han P, et al. Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):91-6. Hepatobiliary Pancreat Dis Int. 2008. PMID: 18234646 - The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats.
Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A, McGarry JD. Dobbins RL, et al. Diabetes. 2002 Jun;51(6):1825-33. doi: 10.2337/diabetes.51.6.1825. Diabetes. 2002. PMID: 12031970 - Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF. Carpentier A, et al. Diabetes. 2000 Mar;49(3):399-408. doi: 10.2337/diabetes.49.3.399. Diabetes. 2000. PMID: 10868961 - Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
Unger RH. Unger RH. Diabetes. 1995 Aug;44(8):863-70. doi: 10.2337/diab.44.8.863. Diabetes. 1995. PMID: 7621989 Review. - Free fatty acids-the link between obesity and insulin resistance.
Boden G. Boden G. Endocr Pract. 2001 Jan-Feb;7(1):44-51. doi: 10.4158/EP.7.1.44. Endocr Pract. 2001. PMID: 11250769 Review.
Cited by
- Relationship between thioredoxin-interacting protein (TXNIP) and islet β-cell dysfunction in patients with impaired glucose tolerance and hypertriglyceridemia.
Zhao YC, Zhu J, Song GY, Li XS. Zhao YC, et al. Int J Clin Exp Med. 2015 Mar 15;8(3):4363-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064354 Free PMC article. - Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets.
Hagman DK, Latour MG, Chakrabarti SK, Fontes G, Amyot J, Tremblay C, Semache M, Lausier JA, Roskens V, Mirmira RG, Jetton TL, Poitout V. Hagman DK, et al. Diabetes. 2008 Feb;57(2):424-31. doi: 10.2337/db07-1285. Epub 2007 Nov 8. Diabetes. 2008. PMID: 17991758 Free PMC article. - Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass.
Peyot ML, Pepin E, Lamontagne J, Latour MG, Zarrouki B, Lussier R, Pineda M, Jetton TL, Madiraju SR, Joly E, Prentki M. Peyot ML, et al. Diabetes. 2010 Sep;59(9):2178-87. doi: 10.2337/db09-1452. Epub 2010 Jun 14. Diabetes. 2010. PMID: 20547980 Free PMC article. - Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.
Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE. Hull RL, et al. Diabetologia. 2005 Jul;48(7):1350-8. doi: 10.1007/s00125-005-1772-9. Epub 2005 Jun 4. Diabetologia. 2005. PMID: 15937671 - Influence of endogenous NEFA on beta cell function in humans.
Rebelos E, Seghieri M, Natali A, Balkau B, Golay A, Piatti PM, Lalic NM, Laakso M, Mari A, Ferrannini E. Rebelos E, et al. Diabetologia. 2015 Oct;58(10):2344-51. doi: 10.1007/s00125-015-3685-6. Epub 2015 Jul 10. Diabetologia. 2015. PMID: 26160433
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous